Mirabegron exhibits antibacterial and Immunomodulatory activities demonstrated by in vitro and in vivo studies. [PDF]
Ahmed EA, Abd-Eldayem AM.
europepmc +1 more source
Strategy for Withdrawal of Pharmacological Treatment for Urinary Incontinence in Children (StayDry): Protocol for an Open-Label Prospective Randomized Trial. [PDF]
Svendsen AM +7 more
europepmc +1 more source
Integrating Artificial intelligence within sustainable smart analytical chemistry for analyzing the divisor impact on UV-spectrophotometric efficiency of solifenacin and mirabegron combination. [PDF]
Lotfy HM +3 more
europepmc +1 more source
Copper(II)-Catalyzed Selective CAr-H Bond Formylation: Synthesis of Dialdehyde Aniline. [PDF]
Guo S, Li Y, Fan W, Liu Z, Huang D.
europepmc +1 more source
<i>N</i>-(3-Chloro-4-hy-droxy-phen-yl)acetamide. [PDF]
Uppu RM, Fronczek FR.
europepmc +1 more source
Eco-friendly spectrophotometric quantification of the potential combination of mirabegron and tamsulosin. [PDF]
El-Abassy OM +3 more
europepmc +1 more source
β<sub>3</sub>-Adrenoceptor Agonist Effects on the Urinary Bladder Beyond Detrusor Relaxation. [PDF]
Michel MC, Arioglu-Inan E, Hennenberg M.
europepmc +1 more source
TRPA1 for Butterfly Eyespot Formation. [PDF]
Ozaki M, Otaki JM.
europepmc +1 more source
Green HPLC technique development for the simultaneous determination of the potential combination of Mirabegron and Tamsulosin. [PDF]
Bahgat EA +3 more
europepmc +1 more source
A comparative study of mirabegron versus doxazosin in improving ureteral stent-related dysfunction. [PDF]
Tao B +5 more
europepmc +1 more source

